Adaptation to light begins almost immediately, but requires more than 1 min to reach a steady state. In this study, the change in color appearance with chromatic adaptation is followed for 5 min after the onset of adapting light. Several different adapting fields are used: (1) a full background with
Pharmacokinetic analysis of the time course of effect of atracurium
β Scribed by Warwick, Neil R.; Graham, Garry G.; Torda, Thomas A.
- Publisher
- Nature Publishing Group
- Year
- 1995
- Tongue
- English
- Weight
- 759 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0009-9236
No coin nor oath required. For personal study only.
β¦ Synopsis
Pharmacokinetic analysis of the time course of effect of atracurium
Objechve: To examine the ability to determine clinically important pharmacokinetic and pharmacody namic parameters of atracurium by the analysis of the time course of effect without the use of plasma concentration data. De&n: Neuromuscular transmission was monitored with train-of-four stimulation and electromyographic quantitation of the first (Tl) and fourth (T4) responses in eight anesthetized patients undergoing elective surgery. The time course of onset and recovery of neuromuscular blockade by three successive bolus doses of atracurium was recorded. Equations describing the theoretic time course of concentrations in the effect compartment and the dose-response relationship were fitted simultaneously to these data; the parameters of these equations derived from the fit of two doses were used to predict the response to a third dose. Fitting the equations to all three doses was also performed to assess the accuracy of predictions for atracurimn. Results: From the depression of the first twitch after three consecutive doses in eight patients, the halflives of uptake into and elimination from the effect compartment were 2.1 + 0.2 minutes (mean f SEM) and 25.8 + 2.3 minutes (n = 8). The doses producing 50% and 95% depression of the first twitch (ED,, and ED,,) were 168 -+ 15 and 280 + 25 @kg, respectively, with a Hill coefficient of 6.1 + 0.5. The half-life of elimination estimated from the fourth twitch was similar to that from the first twitch. Conclus~: The analysis of high-resolution effect data is capable of giving pharmacokinetic and pharmacodynamic parameters with clinically acceptable accuracy within a short sampling time, without resorting to laboratory analysis. This method is speciSc for active drng and would be of value for individualization of administration for short-term treatment. (
π SIMILAR VOLUMES
## Abstract Botulinum toxin A (btx) is used to treat focal dystonias. From accidental intoxications it is known that btx can cause generalized pathologic singleβfiber electromyography (SFEMG) findings. We monitored the onset and course of these disturbances in eight patients who received a small do
The aim of the present study was to develop a method for predicting the concentration-time profile in humans based on pharmacokinetic data for animals. The method is based on the assumptions that concentration-time profiles of a drug are similar among species and "normalized curves" from a variety o